UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-03 | -0.57 | -0.57 |
| Q1 2022 | 2022-05-05 | 0.39 | 0.39 |
| Q4 2021 | 2022-02-23 | 1.21 | 1.21 |
| Q3 2021 | 2021-11-08 | -0.69 | -0.69 |
| Q2 2021 | 2021-08-04 | 0.87 | 0.87 |
| Q1 2021 | 2021-05-05 | -0.04 | -0.04 |
| Q4 2020 | 2021-02-23 | -0.24 | -0.24 |
| Q3 2020 | 2020-11-05 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-04 | -0.61 | -0.61 |
| 2016-06-29 | Reiterated Rating | Leerink Swann | Outperform | $18.00 |
| 2016-06-28 | Reiterated Rating | Wedbush | Outperform | $27.00 |
| 2016-06-28 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-05-03 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-05-02 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-05-02 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
| 2016-04-04 | Reiterated Rating | Canaccord Genuity | Buy | $20.00 |
| 2016-03-09 | Reiterated Rating | Oppenheimer | Outperform | $28.00 |
| 2016-03-08 | Lower Price Target | Leerink Swann | Outperform | $22.00 to $18.00 |
| 2016-03-08 | Reiterated Rating | Canaccord Genuity | Buy | $20.00 |
| 2016-01-15 | Reiterated Rating | Canaccord Genuity | Buy | $20.00 |
| 2015-12-28 | Initiated Coverage | Canaccord Genuity | Buy | $20.00 |
| 2015-12-22 | Reiterated Rating | FBR & Co. | Buy | $20.00 |
| 2015-12-22 | Initiated Coverage | Canaccord Genuity | Buy | $20.00 |
| 2015-12-22 | Reiterated Rating | FBR & Co | Buy | $20.00 |
| 2015-11-05 | Reiterated Rating | Oppenheimer | Outperform | $28.00 |
| 2015-09-17 | Reiterated Rating | Wedbush | Buy | $27.00 |
| 2015-09-16 | Reiterated Rating | Leerink Swann | Outperform | $25.00 |
| 2015-08-06 | Reiterated Rating | Wedbush | Outperform | $22.00 to $27.00 |
| 2015-08-05 | Reiterated Rating | MLV & Co. | Buy | $22.00 to $29.00 |
| 2015-06-30 | Initiated Coverage | Oppenheimer | Buy | $28.00 |
| 2015-06-29 | Boost Price Target | Leerink Swann | Outperform | $22.00 to $25.00 |
| 2015-05-06 | Initiated Coverage | Credit Suisse | Outperform | $14.00 |
| 2015-05-06 | Initiated Coverage | Credit Suisse Group AG | Outperform | $14.00 |
| 2015-05-05 | Set Price Target | MLV & Co. | Buy | $22.00 |
| 2015-05-05 | Set Price Target | Oppenheimer | Buy | $28.00 |
| 2015-02-20 | Set Price Target | MLV & Co. | Buy | $22.00 |
| 2015-02-12 | Boost Price Target | Oppenheimer | Outperform | $22.00 to $28.00 |
| 2015-01-30 | Boost Price Target | Wedbush | Outperform | $18.00 to $22.00 |
| 2015-01-28 | Boost Price Target | MLV & Co. | Buy | $18.00 to $22.00 |
| 2015-01-13 | Set Price Target | MLV & Co. | Buy | $18.00 |
| 2014-10-23 | Initiated Coverage | MLV & Co. | Buy | |
| 2014-07-10 | Initiated Coverage | Oppenheimer | Outperform | $22.00 |
| 2014-01-03 | Initiated Coverage | Credit Suisse | Outperform | $14.00 |
| 2013-12-31 | Initiated Coverage | Wedbush | Outperform | |
| 2013-12-30 | Initiated Coverage | Leerink Swann | Outperform | $11.00 |
| 2016-06-29 | Reiterated Rating | Leerink Swann | Outperform | $18.00 |
| 2016-06-28 | Reiterated Rating | Wedbush | Outperform | $27.00 |
| 2016-06-28 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-05-03 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-05-02 | Reiterated Rating | Oppenheimer | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In XNCR 154 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 10.01M |
| Vanguard Group, Inc | 6.56M |
| PRIMECAP MANAGEMENT CO/CA/ | 5.69M |
| EcoR1 Capital, LLC | 5.28M |
| FMR LLC | 5.24M |
| STATE STREET CORP | 3.26M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.21M |
| LOOMIS SAYLES & CO L P | 1.79M |
| BlackRock Fund Advisors | 1.73M |
| DIMENSIONAL FUND ADVISORS LP | 1.16M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.08M |
| BlackRock Institutional Trust Company, N.A. | 0.90M |
| JOHNSON & JOHNSON | 0.75M |
| NORTHERN TRUST CORP | 0.70M |
| GOLDMAN SACHS GROUP INC | 0.52M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| STAFFORD JOHN S III | 17.55% (5511348) | AWRE / XNCR / |
| STAFFORD JOHN S JR | 6.37% (2000443) | AWRE / XNCR / |
| Ronin Trading, LLC | 6.37% (2000000) | XNCR / |
| SARAN ATUL | 4.20% (1319522) | EBS / MGNX / XNCR / |
| WERNER HAROLD R | 3.30% (1035407) | GNVC / XNCR / |
| FLEMING JONATHAN | 2.52% (790881) | RDUS / XNCR / |
| Dahiyat Bassil I President and CEO | 1.16% (365321) | XNCR / |
| Kuch John J Vice President, Finance | 0.29% (92171) | XNCR / |
| Desjarlais John R Vice President, Research | 0.28% (87676) | XNCR / |
| CARTER BRUCE L A | 0.15% (48578) | ENTA / MRTX / RGLS / XNCR / |
| Foster Paul A Chief Medical Officer | 0.01% (2419) | XNCR / |
UM